Alissa Maria D'Gama, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Intensive Care Units, Neonatal | 5 | 2024 | 858 | 1.850 |
Why?
|
| Malformations of Cortical Development | 4 | 2021 | 174 | 1.670 |
Why?
|
| Mosaicism | 4 | 2023 | 481 | 1.260 |
Why?
|
| Epilepsy | 5 | 2023 | 3317 | 1.140 |
Why?
|
| Seizures, Febrile | 1 | 2023 | 109 | 0.800 |
Why?
|
| Mutation | 15 | 2023 | 30209 | 0.730 |
Why?
|
| Neonatology | 1 | 2023 | 142 | 0.710 |
Why?
|
| Optic Atrophy | 1 | 2020 | 78 | 0.680 |
Why?
|
| TOR Serine-Threonine Kinases | 3 | 2021 | 2057 | 0.660 |
Why?
|
| Thiolester Hydrolases | 1 | 2020 | 91 | 0.640 |
Why?
|
| Epilepsies, Partial | 1 | 2023 | 431 | 0.640 |
Why?
|
| Telencephalon | 1 | 2017 | 142 | 0.560 |
Why?
|
| Amino Acid Metabolism, Inborn Errors | 1 | 2020 | 284 | 0.540 |
Why?
|
| Genetic Testing | 4 | 2024 | 3594 | 0.540 |
Why?
|
| Abnormalities, Multiple | 2 | 2020 | 1424 | 0.500 |
Why?
|
| Mitochondrial Proteins | 1 | 2020 | 975 | 0.470 |
Why?
|
| Genomics | 4 | 2024 | 5926 | 0.460 |
Why?
|
| Infant, Newborn | 11 | 2024 | 26381 | 0.400 |
Why?
|
| Developmental Disabilities | 1 | 2020 | 1519 | 0.380 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2015 | 698 | 0.360 |
Why?
|
| Carrier Proteins | 1 | 2020 | 4910 | 0.280 |
Why?
|
| Transcription Factors | 4 | 2024 | 12130 | 0.270 |
Why?
|
| Stem Cells | 1 | 2017 | 3537 | 0.240 |
Why?
|
| High-Throughput Nucleotide Sequencing | 4 | 2021 | 3665 | 0.220 |
Why?
|
| Repressor Proteins | 1 | 2015 | 2974 | 0.220 |
Why?
|
| Muscle Hypotonia | 1 | 2024 | 166 | 0.210 |
Why?
|
| Signal Transduction | 2 | 2017 | 23605 | 0.210 |
Why?
|
| Ontario | 1 | 2023 | 403 | 0.200 |
Why?
|
| Homeodomain Proteins | 2 | 2024 | 2430 | 0.190 |
Why?
|
| Mutation, Missense | 3 | 2024 | 2590 | 0.190 |
Why?
|
| Vigabatrin | 1 | 2021 | 88 | 0.180 |
Why?
|
| Critical Illness | 2 | 2024 | 2749 | 0.170 |
Why?
|
| Movement Disorders | 1 | 2024 | 461 | 0.170 |
Why?
|
| Infant | 7 | 2024 | 36427 | 0.170 |
Why?
|
| Brain | 4 | 2023 | 27177 | 0.160 |
Why?
|
| Transcription Factor AP-2 | 1 | 2019 | 78 | 0.160 |
Why?
|
| Congenital Hypothyroidism | 1 | 2018 | 40 | 0.160 |
Why?
|
| Autistic Disorder | 2 | 2022 | 1238 | 0.160 |
Why?
|
| Diabetes Insipidus | 1 | 2019 | 143 | 0.150 |
Why?
|
| Humans | 33 | 2024 | 766117 | 0.150 |
Why?
|
| Metal Metabolism, Inborn Errors | 1 | 2018 | 14 | 0.150 |
Why?
|
| DNA-Binding Proteins | 1 | 2015 | 9601 | 0.150 |
Why?
|
| Mutagenesis | 1 | 2022 | 1227 | 0.150 |
Why?
|
| Ataxia | 1 | 2020 | 307 | 0.150 |
Why?
|
| Hypoventilation | 1 | 2018 | 44 | 0.150 |
Why?
|
| Myopathies, Structural, Congenital | 1 | 2018 | 104 | 0.150 |
Why?
|
| Focus Groups | 1 | 2024 | 1459 | 0.150 |
Why?
|
| Stereotypic Movement Disorder | 1 | 2017 | 31 | 0.140 |
Why?
|
| Ductus Arteriosus, Patent | 1 | 2019 | 216 | 0.140 |
Why?
|
| Sleep Apnea, Central | 1 | 2018 | 88 | 0.140 |
Why?
|
| Pedigree | 3 | 2020 | 4535 | 0.140 |
Why?
|
| Chromosomes, Human | 1 | 2018 | 437 | 0.130 |
Why?
|
| Minority Groups | 1 | 2024 | 1208 | 0.130 |
Why?
|
| Germ-Line Mutation | 2 | 2021 | 1885 | 0.130 |
Why?
|
| Fingers | 1 | 2019 | 509 | 0.130 |
Why?
|
| Neoplasms, Germ Cell and Embryonal | 1 | 2021 | 483 | 0.130 |
Why?
|
| Rett Syndrome | 1 | 2017 | 163 | 0.120 |
Why?
|
| Cation Transport Proteins | 1 | 2018 | 325 | 0.120 |
Why?
|
| Manganese | 1 | 2018 | 395 | 0.120 |
Why?
|
| Structure-Activity Relationship | 1 | 2020 | 3051 | 0.120 |
Why?
|
| Parkinsonian Disorders | 1 | 2018 | 285 | 0.120 |
Why?
|
| Child | 10 | 2024 | 80573 | 0.120 |
Why?
|
| Loss of Heterozygosity | 1 | 2017 | 663 | 0.120 |
Why?
|
| Dystonic Disorders | 1 | 2018 | 354 | 0.110 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 1 | 2017 | 904 | 0.110 |
Why?
|
| Muscle Proteins | 1 | 2018 | 1160 | 0.110 |
Why?
|
| Face | 1 | 2019 | 1029 | 0.100 |
Why?
|
| Protein Conformation | 1 | 2020 | 3946 | 0.100 |
Why?
|
| Feasibility Studies | 1 | 2023 | 5300 | 0.100 |
Why?
|
| Genetic Predisposition to Disease | 4 | 2021 | 18076 | 0.100 |
Why?
|
| Female | 18 | 2024 | 396233 | 0.100 |
Why?
|
| GTPase-Activating Proteins | 1 | 2015 | 465 | 0.100 |
Why?
|
| Hand | 1 | 2017 | 909 | 0.100 |
Why?
|
| Anticonvulsants | 1 | 2021 | 1920 | 0.090 |
Why?
|
| Cell Lineage | 2 | 2017 | 2573 | 0.090 |
Why?
|
| Child, Preschool | 8 | 2024 | 42511 | 0.090 |
Why?
|
| Health Personnel | 1 | 2024 | 3387 | 0.090 |
Why?
|
| Databases, Genetic | 1 | 2017 | 1756 | 0.090 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2018 | 3796 | 0.090 |
Why?
|
| Prefrontal Cortex | 1 | 2021 | 2224 | 0.090 |
Why?
|
| Molecular Targeted Therapy | 1 | 2021 | 2824 | 0.090 |
Why?
|
| Pilot Projects | 1 | 2023 | 8724 | 0.080 |
Why?
|
| Cohort Studies | 4 | 2023 | 41684 | 0.080 |
Why?
|
| Male | 14 | 2024 | 363935 | 0.080 |
Why?
|
| DNA Mutational Analysis | 2 | 2015 | 4112 | 0.080 |
Why?
|
| Phenotype | 4 | 2020 | 16716 | 0.080 |
Why?
|
| Neurons | 3 | 2017 | 9521 | 0.080 |
Why?
|
| Cerebral Cortex | 2 | 2015 | 5758 | 0.080 |
Why?
|
| Mass Screening | 1 | 2023 | 5450 | 0.070 |
Why?
|
| Sequence Analysis, DNA | 2 | 2015 | 4780 | 0.070 |
Why?
|
| Heart Defects, Congenital | 1 | 2024 | 4712 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2015 | 2455 | 0.060 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2017 | 3606 | 0.060 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2015 | 2877 | 0.060 |
Why?
|
| Aging | 1 | 2022 | 8723 | 0.050 |
Why?
|
| Polymorphism, Single Nucleotide | 3 | 2021 | 16040 | 0.050 |
Why?
|
| Hospitalization | 1 | 2023 | 10811 | 0.050 |
Why?
|
| Genetic Variation | 1 | 2017 | 6612 | 0.050 |
Why?
|
| Transcription, Genetic | 1 | 2015 | 7600 | 0.050 |
Why?
|
| Australia | 1 | 2024 | 1260 | 0.050 |
Why?
|
| Germinoma | 1 | 2021 | 124 | 0.040 |
Why?
|
| Brain Neoplasms | 1 | 2021 | 9065 | 0.040 |
Why?
|
| Canada | 1 | 2024 | 2120 | 0.040 |
Why?
|
| Animals | 3 | 2021 | 168800 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 10 | 1 | 2019 | 275 | 0.040 |
Why?
|
| Young Adult | 3 | 2021 | 59868 | 0.040 |
Why?
|
| Adolescent | 5 | 2021 | 88819 | 0.040 |
Why?
|
| Sequence Analysis | 1 | 2018 | 240 | 0.040 |
Why?
|
| Colorectal Neoplasms | 1 | 2017 | 6961 | 0.030 |
Why?
|
| Zygote | 1 | 2017 | 117 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 2019 | 640 | 0.030 |
Why?
|
| Consanguinity | 1 | 2018 | 460 | 0.030 |
Why?
|
| Chelating Agents | 1 | 2018 | 380 | 0.030 |
Why?
|
| Embryonic Development | 1 | 2021 | 719 | 0.030 |
Why?
|
| Muscle Weakness | 1 | 2018 | 412 | 0.030 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2022 | 1363 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2020 | 36548 | 0.030 |
Why?
|
| Growth Substances | 1 | 2017 | 758 | 0.030 |
Why?
|
| Classical Lissencephalies and Subcortical Band Heterotopias | 1 | 2014 | 13 | 0.030 |
Why?
|
| Exons | 1 | 2021 | 2393 | 0.030 |
Why?
|
| Testicular Neoplasms | 1 | 2021 | 800 | 0.030 |
Why?
|
| Lissencephaly | 1 | 2014 | 36 | 0.030 |
Why?
|
| Periventricular Nodular Heterotopia | 1 | 2014 | 57 | 0.030 |
Why?
|
| Genome-Wide Association Study | 1 | 2013 | 12803 | 0.030 |
Why?
|
| Cell Division | 1 | 2021 | 4466 | 0.030 |
Why?
|
| Chromosome Aberrations | 1 | 2019 | 1775 | 0.030 |
Why?
|
| Gene Regulatory Networks | 1 | 2021 | 1750 | 0.020 |
Why?
|
| Video Recording | 1 | 2017 | 977 | 0.020 |
Why?
|
| Mice | 1 | 2017 | 81839 | 0.020 |
Why?
|
| Mitosis | 1 | 2015 | 1175 | 0.020 |
Why?
|
| Seizures | 1 | 2023 | 2997 | 0.020 |
Why?
|
| Protein Binding | 1 | 2022 | 9301 | 0.020 |
Why?
|
| Central Nervous System | 1 | 2017 | 1343 | 0.020 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2017 | 1935 | 0.020 |
Why?
|
| Genetic Association Studies | 1 | 2018 | 2744 | 0.020 |
Why?
|
| Logistic Models | 1 | 2024 | 13273 | 0.020 |
Why?
|
| Chromatin | 1 | 2021 | 2981 | 0.020 |
Why?
|
| DNA Replication | 1 | 2015 | 1428 | 0.020 |
Why?
|
| Genome, Human | 1 | 2021 | 4443 | 0.020 |
Why?
|
| Receptors, Cell Surface | 1 | 2017 | 2815 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2017 | 6493 | 0.020 |
Why?
|
| Epigenesis, Genetic | 1 | 2021 | 3818 | 0.020 |
Why?
|
| Biopsy | 1 | 2018 | 6768 | 0.020 |
Why?
|
| Genetic Loci | 1 | 2015 | 2630 | 0.020 |
Why?
|
| Adult | 1 | 2020 | 223139 | 0.020 |
Why?
|
| Genotype | 1 | 2019 | 13028 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2022 | 11906 | 0.010 |
Why?
|
| Single-Cell Analysis | 1 | 2015 | 2536 | 0.010 |
Why?
|
| Retrospective Studies | 2 | 2024 | 81565 | 0.010 |
Why?
|
| Muscle, Skeletal | 1 | 2018 | 4959 | 0.010 |
Why?
|
| Middle Aged | 1 | 2015 | 223083 | 0.010 |
Why?
|
| Pregnancy | 1 | 2021 | 30233 | 0.010 |
Why?
|
| Prognosis | 1 | 2018 | 29912 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2013 | 18967 | 0.010 |
Why?
|
| Rats | 1 | 2013 | 23717 | 0.010 |
Why?
|
| United States | 1 | 2024 | 72920 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2021 | 54812 | 0.010 |
Why?
|